Global Fund Continues To Support Programs To Address Drug-Resistant TB

Friends of the Global Fight: Countering Drug Resistance in Tuberculosis, the World’s Most Lethal Epidemic
In the first in a series of blog posts exploring the threat that drug resistance poses in addressing the HIV/AIDS, tuberculosis (TB), and malaria epidemics, Mark P. Lagon, chief policy officer at Friends, and Anna Carroll discuss the challenges of drug-resistant TB and the Global Fund’s work to support TB programs (10/4).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.